Hasil Pencarian - Delong Liu

Perbaiki Hasil
  1. 1
    Cancer biomarkers for targeted therapy

    Cancer biomarkers for targeted therapy oleh Delong Liu

    Diterbitkan 2019-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Journal of Hematology & Oncology reviewer acknowledgement 2015

    Journal of Hematology & Oncology reviewer acknowledgement 2015 oleh Delong Liu

    Diterbitkan 2016-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    CAR-T “the living drugs”, immune checkpoint inhibitors, and precision medicine: a new era of cancer therapy

    CAR-T “the living drugs”, immune checkpoint inhibitors, and precision medicine: a new era of cancer therapy oleh Delong Liu

    Diterbitkan 2019-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Antibody-drug conjugates in clinical trials for lymphoid malignancies and multiple myeloma

    Antibody-drug conjugates in clinical trials for lymphoid malignancies and multiple myeloma oleh Bo Yu, Delong Liu

    Diterbitkan 2019-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Frontline therapies for untreated chronic lymphoid leukemia

    Frontline therapies for untreated chronic lymphoid leukemia oleh Delong Liu, Juanjuan Zhao

    Diterbitkan 2019-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Gemtuzumab ozogamicin and novel antibody-drug conjugates in clinical trials for acute myeloid leukemia

    Gemtuzumab ozogamicin and novel antibody-drug conjugates in clinical trials for acute myeloid leukemia oleh Bo Yu, Delong Liu

    Diterbitkan 2019-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Correction to: Antibody-drug conjugates in clinical trials for lymphoid malignancies and multiple myeloma

    Correction to: Antibody-drug conjugates in clinical trials for lymphoid malignancies and multiple myeloma oleh Bo Yu, Delong Liu

    Diterbitkan 2020-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    Cytokine release syndrome: grading, modeling, and new therapy

    Cytokine release syndrome: grading, modeling, and new therapy oleh Delong Liu, Juanjuan Zhao

    Diterbitkan 2018-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    Syk inhibitors in clinical development for hematological malignancies

    Syk inhibitors in clinical development for hematological malignancies oleh Delong Liu, Aleksandra Mamorska-Dyga

    Diterbitkan 2017-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    Recent advances on blinatumomab for acute lymphoblastic leukemia

    Recent advances on blinatumomab for acute lymphoblastic leukemia oleh Juanjuan Zhao, Yongping Song, Delong Liu

    Diterbitkan 2019-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  11. 11
    Gilteritinib: a novel FLT3 inhibitor for acute myeloid leukemia

    Gilteritinib: a novel FLT3 inhibitor for acute myeloid leukemia oleh Juanjuan Zhao, Yongping Song, Delong Liu

    Diterbitkan 2019-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  12. 12
    Clinical trials of CAR-T cells in China

    Clinical trials of CAR-T cells in China oleh Bingshan Liu, Yongping Song, Delong Liu

    Diterbitkan 2017-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  13. 13
    BCMA-targeted immunotherapy for multiple myeloma

    BCMA-targeted immunotherapy for multiple myeloma oleh Bo Yu, Tianbo Jiang, Delong Liu

    Diterbitkan 2020-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  14. 14
    Second- and third-generation ALK inhibitors for non-small cell lung cancer

    Second- and third-generation ALK inhibitors for non-small cell lung cancer oleh Jingjing Wu, John Savooji, Delong Liu

    Diterbitkan 2016-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  15. 15
    Clinical applications of PD-L1 bioassays for cancer immunotherapy

    Clinical applications of PD-L1 bioassays for cancer immunotherapy oleh Delong Liu, Shuhang Wang, Wendy Bindeman

    Diterbitkan 2017-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  16. 16
    SETBP1 mutations as a biomarker for myelodysplasia /myeloproliferative neoplasm overlap syndrome

    SETBP1 mutations as a biomarker for myelodysplasia /myeloproliferative neoplasm overlap syndrome oleh Katherine Linder, Chaitanya Iragavarapu, Delong Liu

    Diterbitkan 2017-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  17. 17
    Comprehensive analysis and treatment of intraoral thyroglossal duct cysts with intraoperative techniques: a 7-case series review in a tertiary care center

    Comprehensive analysis and treatment of intraoral thyroglossal duct cysts with intraoperative techniques: a 7-case series review in a tertiary care center oleh Bo Li, Cuiping She, Delong Liu

    Diterbitkan 2024-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  18. 18
    Inotuzumab ozogamicin in clinical development for acute lymphoblastic leukemia and non-Hodgkin lymphoma

    Inotuzumab ozogamicin in clinical development for acute lymphoblastic leukemia and non-Hodgkin lymphoma oleh Amandeep Aujla, Ravijot Aujla, Delong Liu

    Diterbitkan 2019-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  19. 19
    Third-generation inhibitors targeting EGFR T790M mutation in advanced non-small cell lung cancer

    Third-generation inhibitors targeting EGFR T790M mutation in advanced non-small cell lung cancer oleh Shuhang Wang, Shundong Cang, Delong Liu

    Diterbitkan 2016-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  20. 20
    Recent development in clinical applications of PD-1 and PD-L1 antibodies for cancer immunotherapy

    Recent development in clinical applications of PD-1 and PD-L1 antibodies for cancer immunotherapy oleh Bingshan Liu, Yongping Song, Delong Liu

    Diterbitkan 2017-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: